Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: P2C 8317 Principal Investigator: Adkins, Douglas
Title: Phase I/II trial of Cediranib alone or Cediranib and Lenalidomide in iodine 131-refractory differentiated thyroid cancer
Phase: I/II Disease Site: Thyroid
Participating Site(s):
 
Main Campus
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The uprpose of this study is to learn about the side effects and determine the best dose of cediranib maleate when given with or without lenalidomide and to see how well they work in treating patients with thyroid cancer.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)